These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35901604)

  • 1. Quality of life and physical functioning in black and white adults with hypertrophic cardiomyopathy.
    Arabadjian M; Yu G; Vorderstrasse A; Sherrid MV; Dickson VV
    Heart Lung; 2022; 56():142-147. PubMed ID: 35901604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy.
    Arabadjian ME; Yu G; Sherrid MV; Dickson VV
    J Am Heart Assoc; 2021 Sep; 10(17):e019978. PubMed ID: 34431363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of exercise rehabilitation in patients with hypertrophic cardiomyopathy.
    Wasserstrum Y; Barbarova I; Lotan D; Kuperstein R; Shechter M; Freimark D; Segal G; Klempfner R; Arad M
    J Cardiol; 2019 Nov; 74(5):466-472. PubMed ID: 31235420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
    Huff CM; Turer AT; Wang A
    Qual Life Res; 2013 Apr; 22(3):647-52. PubMed ID: 22544415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Khan R; Massel D; Stirrat J; Scholl D; Wisenberg G; Thompson T; Drangova M; White JA
    Int J Cardiovasc Imaging; 2013 Feb; 29(2):395-404. PubMed ID: 22875171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.
    Wasserstrum Y; Barriales-Villa R; Fernández-Fernández X; Adler Y; Lotan D; Peled Y; Klempfner R; Kuperstein R; Shlomo N; Sabbag A; Freimark D; Monserrat L; Arad M
    Eur Heart J; 2019 Jun; 40(21):1671-1677. PubMed ID: 30358878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired left ventricular mechanics and functional reserve are associated with reduced exercise capacity in patients with hypertrophic cardiomyopathy.
    Wu XP; Li YD; Zhang M; Zhu WW; Cai QZ; Jiang W; Sun LL; Ding XY; Ye XG; Qin YY; Lu XZ
    Echocardiography; 2019 Feb; 36(2):266-275. PubMed ID: 30600556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.
    Capota R; Militaru S; Ionescu AA; Rosca M; Baicus C; Popescu BA; Jurcut R
    Health Qual Life Outcomes; 2020 Oct; 18(1):351. PubMed ID: 33126893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center.
    Klempfner R; Kamerman T; Schwammenthal E; Nahshon A; Hay I; Goldenberg I; Dov F; Arad M
    Eur J Prev Cardiol; 2015 Jan; 22(1):13-9. PubMed ID: 23928567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated Review of Hypertrophic Cardiomyopathy in Black Populations: Underrecognized and Understudied.
    Arabadjian M; McCarthy M; Dickson VV
    J Cardiovasc Nurs; 2021 Mar-Apr 01; 36(2):104-115. PubMed ID: 33565785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.
    Desai N; Xie J; Wang Y; Sutton MB; Whang J; Fine JT; Garrison LP
    Clin Ther; 2022 Jan; 44(1):52-66.e2. PubMed ID: 34911641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Dybro AM; Rasmussen TB; Nielsen RR; Andersen MJ; Jensen MK; Poulsen SH
    J Am Coll Cardiol; 2021 Dec; 78(25):2505-2517. PubMed ID: 34915981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design.
    Coats CJ; Maron MS; Abraham TP; Olivotto I; Lee MMY; Arad M; Cardim N; Ma CS; Choudhury L; Düngen HD; Garcia-Pavia P; Hagège AA; Lewis GD; Michels M; Oreziak A; Owens AT; Tfelt-Hansen J; Veselka J; Watkins HC; Heitner SB; Jacoby DL; Kupfer S; Malik FI; Meng L; Wohltman A; Masri A;
    JACC Heart Fail; 2024 Jan; 12(1):199-215. PubMed ID: 38032573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.
    Shah AB; Bechis MZ; Brown M; Finch JM; Loomer G; Groezinger E; Weiner RB; Wasfy MM; Picard MH; Fifer MA; Lewis GB; Baggish AL
    J Physiol; 2019 Mar; 597(5):1337-1346. PubMed ID: 30552684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.
    Ghiselli L; Marchi A; Fumagalli C; Maurizi N; Oddo A; Pieri F; Girolami F; Rowin E; Mazzarotto F; Cicoira M; Ribichini F; Arretini A; Targetti M; Passantino S; Cecchi F; Marchionni N; Maron M; Mori F; Olivotto I
    Eur J Prev Cardiol; 2020 Nov; 27(17):1821-1831. PubMed ID: 31698967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.